HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.

LifeMD does accept some insurance plans for medication, though this varies depending on the provider and medication. The LifeMD Weight Management Program does not include the cost of medication.

A unique business structure gives LifeMD access to the growing GLP-1 marketplace that can help boost the heavily shorted stock price. Read an analysis of LFMD here.

LifeMD's stock has roughly tripled in 2025 as its telehealth business is delivering stellar revenue growth. Click for my updated look at LFMD stock prospects.

LifeMD is bordering on breakeven, according to the 7 American Healthcare Services analysts. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$2.3m ...

Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and wellness needs, while LifeMD is a direct-to-patient telehealth company that provides a cost-effective ...

LifeMD announces a cash dividend of $0.5546875 per share for its 8.875% Series A Preferred Stock, payable July 15, 2025.

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

LifeMD , Inc. (NASDAQ:LFMD), a provider of telehealth services and products with a market capitalization of $613 million, conducted its annual meeting of stockholders on June 13, 2025, where it ...

LifeMD is diversifying across new service lines including Hormone Replacement Therapy, mental health, and women’s health, according to BTIG’s analysis.

LifeMD , Inc. (NASDAQ:LFMD), a provider of telehealth services and products with a market capitalization of $613 million, conducted its annual meeting of stockholders on June 13, 2025, where it ...